Literature DB >> 25063871

Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.

Deanna Lamont1, Gayatri Mukherjee2, P Rajesh Kumar3, Dibyendu Samanta2, Caroline G McPhee1, Thomas W H Kay4, Steven C Almo3, Teresa P DiLorenzo5, David V Serreze6.   

Abstract

Self-reactive T cells must escape thymic negative selection to mediate pathogenic autoimmunity. In the NOD mouse model of autoimmune diabetes, several β cell-cytotoxic CD8 T cell populations are known, with the most aggressive of these represented by AI4, a T cell clone with promiscuous Ag-recognition characteristics. We identified a long-elusive β cell-specific ligand for AI4 as an unusually short H-2D(b)-binding 7-mer peptide lacking a C-terminal anchor residue and derived from the insulin A chain (InsA14-20). Crystallography reveals that compensatory mechanisms permit peptides lacking a C-terminal anchor to bind sufficiently to the MHC to enable destructive T cell responses, yet allow cognate T cells to avoid negative selection. InsA14-20 shares two solvent-exposed residues with previously identified AI4 ligands, providing a structural explanation for AI4's promiscuity. Detection of AI4-like T cells, using mimotopes of InsA14-20 with improved H-2D(b)-binding characteristics, establishes the AI4-like T cell population as a consistent feature of the islet infiltrates of NOD mice. Our work establishes undersized peptides as previously unrecognized targets of autoreactive CD8 T cells and presents a strategy for their further exploration as Ags in autoimmune disease.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25063871      PMCID: PMC4134999          DOI: 10.4049/jimmunol.1400997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors:  F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

2.  Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.

Authors:  A Glithero; J Tormo; J S Haurum; G Arsequell; G Valencia; J Edwards; S Springer; A Townsend; Y L Pao; M Wormald; R A Dwek; E Y Jones; T Elliott
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

3.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis.

Authors:  Michael Strong; Michael R Sawaya; Shuishu Wang; Martin Phillips; Duilio Cascio; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

4.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.

Authors:  D N Garboczi; P Ghosh; U Utz; Q R Fan; W E Biddison; D C Wiley
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

5.  Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.

Authors:  Scott M Lieberman; Toshiyuki Takaki; Bingye Han; Pere Santamaria; David V Serreze; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

6.  Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.

Authors:  D V Serreze; E H Leiter; G J Christianson; D Greiner; D C Roopenian
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

7.  Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement.

Authors:  T P DiLorenzo; R T Graser; T Ono; G J Christianson; H D Chapman; D C Roopenian; S G Nathenson; D V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate.

Authors:  Ann Glithero; Jose Tormo; Klaus Doering; Mayumi Kojima; E Yvonne Jones; Tim Elliott
Journal:  J Biol Chem       Date:  2006-02-14       Impact factor: 5.157

9.  A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.

Authors:  D Schmidt; J Verdaguer; N Averill; P Santamaria
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

10.  Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Authors:  J Verdaguer; D Schmidt; A Amrani; B Anderson; N Averill; P Santamaria
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  14 in total

1.  Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.

Authors:  John P Driver; Jeremy J Racine; Cheng Ye; Deanna J Lamont; Brittney N Newby; Caroline M Leeth; Harold D Chapman; Todd M Brusko; Yi-Guang Chen; Clayton E Mathews; David V Serreze
Journal:  Diabetes       Date:  2016-12-05       Impact factor: 9.461

2.  Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.

Authors:  Jennifer Schloss; Riyasat Ali; Jeffrey Babad; Ignacio Guerrero-Ros; Jillamika Pongsachai; Li-Zhen He; Tibor Keler; Teresa P DiLorenzo
Journal:  Immunohorizons       Date:  2019-06-26

3.  Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Authors:  Gayatri Mukherjee; Rodolfo J Chaparro; Jennifer Schloss; Carla Smith; Christopher D Bando; Teresa P DiLorenzo
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

4.  Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.

Authors:  Sigal Fishman; Mark D Lewis; L Khai Siew; Evy De Leenheer; Dimitri Kakabadse; Joanne Davies; Doron Ziv; Alon Margalit; Nathan Karin; Gideon Gross; F Susan Wong
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

5.  A Hypermorphic Nfkbid Allele Contributes to Impaired Thymic Deletion of Autoreactive Diabetogenic CD8+ T Cells in NOD Mice.

Authors:  Maximiliano Presa; Jeremy J Racine; Jennifer R Dwyer; Deanna J Lamont; Jeremy J Ratiu; Vishal Kumar Sarsani; Yi-Guang Chen; Aron Geurts; Ingo Schmitz; Timothy Stearns; Jennifer Allocco; Harold D Chapman; David V Serreze
Journal:  J Immunol       Date:  2018-08-20       Impact factor: 5.422

6.  Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.

Authors:  E Nikoopour; O Krougly; E Lee-Chan; S M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

7.  Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.

Authors:  J Babad; G Mukherjee; A Follenzi; R Ali; B O Roep; L D Shultz; P Santamaria; O O Yang; H Goldstein; D L Greiner; T P DiLorenzo
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

8.  Observing Islet Function and Islet-Immune Cell Interactions in Live Pancreatic Tissue Slices.

Authors:  Mollie K Huber; Denise M Drotar; Helmut Hiller; Maria L Beery; Paul Joseph; Irina Kusmartseva; Stephan Speier; Mark A Atkinson; Clayton E Mathews; Edward A Phelps
Journal:  J Vis Exp       Date:  2021-04-12       Impact factor: 1.355

Review 9.  Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.

Authors:  François-Xavier Mauvais; Julien Diana; Peter van Endert
Journal:  F1000Res       Date:  2016-04-22

Review 10.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.

Authors:  James A Pearson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2015-09-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.